logo

For the Inventor, By the Inventor

Montpellier, France

Jean-Marc Kamenka

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent. Top assignees: Centre National De La Recherche Scientifique, Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.), Societe D'expansion Scientifique Expansia. Active years: 1993-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Marc Kamenka. Retrieved from https://idiyas.com/inventor/jean-marc-kamenka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 87.5


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:

goldMedal4 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
silverMedal3 out of 119 
 
Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.)
 patents
bronzeMedal1 out of 6 
 
Societe D'expansion Scientifique Expansia
 patents

Years Active: 1993-2004

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 6784194 - Therapeutic use of a thienylcyclohexylamine derivative (2004-08-31),
2. 6514967 - Compound for preparing medicines for treating pathologies involving extracellular glutamate, and methods for obtaining same (2003-02-04),
3. 6342511 - Phencyclidine derivatives, preparation method and pharmaceutical compositions containing same (2002-01-29),
4. 6207685 - Therapeutic application of a thienycyclohexylamine derivative (2001-03-27),
5. 6107495 - Thienylcyclohexane derivatives for thienylcyclohexyl synthesis (2000-08-22),
6. 5972952 - Neuroprotective pharmaceutical composition containing stereoisomers of (1999-10-26),
7. 5248686 - Substituted cyclic amines and pharmaceutical composition containing them (1993-09-28),
8. 5179109 - Pharmaceutical compositions for neuroprotection containing (1993-01-12),

Title: The Innovations of Jean-Marc Kamenka

Introduction

Jean-Marc Kamenka is a notable inventor based in Montpellier, France. He has made significant contributions to the field of therapeutic applications, holding a total of 8 patents. His work focuses on innovative methods to combat neurotoxic effects in warm-blooded animals.

Latest Patents

Among his latest patents is a method for inhibiting the effects of exogenous neurotoxic or neurotoxinic products in warm-blooded animals. This involves administering a reversible cholinesterase inhibitor, such as pyridostigmine or physostigmine, followed by a specific compound in a pure form. Another significant patent involves the preparation of medicines for treating pathologies related to extracellular glutamate, along with methods for obtaining these compounds.

Career Highlights

Jean-Marc Kamenka has worked with prestigious organizations, including the Centre National de la Recherche Scientifique and Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS). His career reflects a commitment to advancing scientific knowledge and therapeutic practices.

Collaborations

Throughout his career, Kamenka has collaborated with esteemed colleagues, including Alain Privat and Guy Lallement. These partnerships have contributed to the development of his innovative ideas and patents.

Conclusion

Jean-Marc Kamenka's contributions to the field of therapeutics demonstrate his dedication to innovation and research. His patents reflect a deep understanding of neurotoxicology and its implications for warm-blooded animals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…